Archive · 27 Dec 2025
Modern Diagnostic Plans ₹37 Crore IPO
Modern Diagnostic & Research Centre is a company that provides healthcare testing services.
They are planning to raise ₹37 crore by selling shares to the public for the first time, which is called an IPO.
The IPO will be on the BSE SME platform, and the shares will cost between ₹85 and ₹90 each.
The money raised will be used to buy new medical equipment, pay off some debts, and help the company grow.
The IPO starts on December 31.
The company's leader, Dr. Devendra Singh Yadav, says this will help them expand and improve their services.
Modern Diagnostic & Research Centre plans to raise ₹37 crore through an IPO on the BSE SME platform.
The company will offer 40.99 lakh equity shares at a price band of ₹85-₹90 per share.
The IPO opens for bidding on December 31.
Proceeds will be used for purchasing medical equipment, working capital, repaying borrowings, and general corporate purposes.
Beeline Capital Advisors is the Book-Running Lead Manager, and MUFG Intime India is the Registrar.
- Who
- Modern Diagnostic & Research Centre
- What
- Plans to raise ₹37 crore through an IPO
- When
- IPO opens on December 31
- Where
- BSE SME platform
- Why
- To purchase medical equipment, meet working capital requirements, repay borrowings, and for general corporate purposes
- Company
- Modern Diagnostic & Research Centre
- IPO Amount
- ₹37 crore
- Platform
- BSE SME
- Shares Offered
- 40.99 lakh
- Price Band
- ₹85-₹90 per share
- IPO Opening Date
- December 31
- Lead Manager
- Beeline Capital Advisors
- Registrar
- MUFG Intime India
